5-Bromo-3-Nitro-2-Pyridinamine Equivalent for Pharma Intermediate
Procuring High-Purity 5-Bromo-3-Nitro-2-Pyridinamine Equivalents for Pharma Intermediate Synthesis
2-Amino-5-bromo-3-nitropyridine (CAS: 6945-68-2) functions as a critical heterocyclic compound in the construction of complex pharmaceutical architectures. This pyridine derivative serves as a foundational building block for synthesizing kinase inhibitors and targeted protein degraders. When sourcing this material, procurement managers must prioritize industrial purity and consistent batch-to-batch reproducibility to ensure downstream reaction efficiency. The chemical structure, often referenced as 5-Bromo-3-Nitro-2-Pyridinamine, contains reactive nitro and amino groups that facilitate nucleophilic substitution and reduction reactions essential for drug discovery pipelines.
Reliable supply chains for 2-Amino-5-bromo-3-nitropyridine as a key 5-Bromo-3-Nitro-2-Pyridinamine pharma intermediate require manufacturers capable of scaling from gram-level screening to multi-kilogram production. NINGBO INNO PHARMCHEM CO.,LTD. maintains strict control over the manufacturing process, ensuring that the 3-nitro-5-bromopyridin-2-amine supplied meets rigorous spectral standards. Impurities such as residual solvents, heavy metals, or isomeric byproducts must be quantified and minimized to prevent catalyst poisoning in subsequent synthetic steps. Procurement strategies should focus on vendors who provide full transparency regarding synthesis routes and purification methods, rather than generic catalog listings.
Quality Verification: NMR, HPLC, and LC-MS Profiles for 2-Amino-5-bromo-3-nitropyridine
Analytical validation is the cornerstone of accepting any chemical raw material into an R&D inventory. For 2-Amino-5-bromo-3-nitropyridine, structural confirmation relies on proton and carbon NMR spectroscopy to verify the substitution pattern on the pyridine ring. The presence of the bromine atom at the 5-position and the nitro group at the 3-position creates distinct chemical shifts that must align with reference spectra. Deviations in these shifts often indicate the presence of regioisomers, such as 5-bromo-3-nitro-pyridin-2-ylamine variants, which can compromise biological assay results.
Quantitative purity is assessed via High-Performance Liquid Chromatography (HPLC) and Liquid Chromatography-Mass Spectrometry (LC-MS). HPLC profiles determine the area percentage of the main peak relative to impurities, while LC-MS confirms the molecular weight and detects trace organic contaminants. The following table outlines the typical specification parameters required for high-grade research materials compared to standard industrial grades:
| Parameter | Standard Industrial Grade | High-Purity R&D Grade | Analysis Method |
|---|---|---|---|
| Purity (Area %) | ≥ 95.0% | ≥ 98.0% - 99.0% | HPLC |
| Water Content | ≤ 1.0% | ≤ 0.5% | Karl Fischer |
| Residual Solvents | Not Specified | ICH Q3C Compliant | GC-MS |
| Heavy Metals | ≤ 20 ppm | ≤ 10 ppm | ICP-MS |
| Structure Confirmation | IR Spectrum | 1H NMR, 13C NMR, LC-MS | Spectroscopy |
Batch-specific Certificates of Analysis (COA) must accompany every shipment, detailing these metrics. R&D teams should verify that the LC-MS data confirms the expected mass-to-charge ratio corresponding to the molecular formula C5H4BrN3O2. Any discrepancy in the mass profile suggests potential degradation or incorrect synthesis, necessitating immediate quarantine of the material.
Cold Chain Logistics: Dry Ice Shipping and Glass Packaging for Nitropyridine Stability
Chemical stability during transit is paramount for nitropyridine derivatives, which can be sensitive to thermal fluctuations and moisture. To maintain integrity, shipments often require cold chain logistics involving dry ice or blue ice packaging, particularly for pre-dissolved solutions or temperature-sensitive batches. Ambient temperature exposure during long-distance freight can accelerate decomposition or promote hydrolysis of the nitro group, altering the chemical profile before the material reaches the laboratory.
Packaging material selection also influences stability. For liquid formulations or solutions exceeding 1mL, glass packaging is mandatory to prevent leaching of plasticizers or adsorption of the compound onto polymer walls. Glass containers provide an inert barrier that protects the 2-Pyridinamine 5-bromo-3-nitro structure from environmental contaminants. Solid forms should be sealed in airtight, light-resistant containers to prevent photodegradation, as nitro compounds can undergo photochemical reactions upon exposure to UV light. Proper labeling indicating storage conditions and hazard classifications ensures safe handling upon receipt.
R&D Support: Custom DMSO Solubility and Technical Consultation for Pyridine Derivatives
Solubility data is critical for high-throughput screening and biological assays. 2-Amino-5-bromo-3-nitropyridine is frequently supplied as a stock solution in Dimethyl Sulfoxide (DMSO) at concentrations such as 10mM. This standardization allows researchers to immediately utilize the compound in cell-based assays without preliminary solubility testing. For volumes under 10mL, custom dissolution services are often available to ensure the compound is fully solubilized and filtered for particulate matter before delivery.
Technical consultation extends beyond simple solubility metrics. Expert support should cover synthesis route optimization, compatibility with specific reaction conditions, and literature search assistance. Understanding the behavior of this pyridine derivative in various solvent systems helps prevent precipitation during assay execution. Vendors capable of providing online technical Q&A facilitate faster problem resolution when unexpected results occur during experimentation. Access to free literature searches regarding similar heterocyclic compounds can also accelerate the design of analogs around the 5-bromo-3-nitro-pyridin-2-ylamine scaffold.
Order Flexibility: Pre-Packaged Specifications and Minimum Quantities for Drug Discovery
Drug discovery workflows require flexible ordering options to accommodate different stages of development. Early-stage screening may only require minimum specifications of 25mg to 100mg, allowing for cost-effective evaluation of multiple analogs. Conversely, lead optimization and process development phases demand bulk quantities ranging from grams to kilograms. Pre-packaged specifications streamline the procurement process, reducing lead times for urgent research needs.
NINGBO INNO PHARMCHEM CO.,LTD. supports scalable supply chains, offering volumes from milligram-scale samples to ton-level production lots. This flexibility ensures that once a candidate is selected, the supply chain can expand without requiring re-qualification of a new vendor. Minimum order quantities should align with project budgets, with options for pre-packaged products available for rapid deployment. Whether sourcing for initial hit identification or large-scale synthesis, the ability to adjust order sizes without compromising quality specifications is essential for maintaining project momentum.
To request a batch-specific COA, SDS, or secure a bulk pricing quote, please contact our technical sales team.